EpiThany Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

EpiThany General Information

Description

Developer of a new class of anti-cancer immunotherapy designed to treat patients with solid tumors. The company's immunotherapy focuses on developing tumor vaccines that drive Th1 (tumor-eradicating) immune responses without stimulating competitive Th2 (tumor-tolerant) responses, enabling physicians to target myriad tumor antigens across a spectrum of cancers, yielding a deep pipeline of Th1-selective anti-cancer vaccines

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 3240 Fuhrman Avenue East
  • Suite 106
  • Seattle, WA 98102
  • United States
+1 (206) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiThany Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Clinical Trials - Phase 1
To view EpiThany’s complete valuation and funding history, request access »

EpiThany Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a new class of anti-cancer immunotherapy designed to treat patients with solid tumors. The company's immuno
Biotechnology
Seattle, WA
00000 00000

00000000

liqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea comm
0000 000000000
Rockville, MD
00 As of 0000
0000
000000000 - 0000

000000 0

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EpiThany Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immunomic Therapeutics Venture Capital-Backed Rockville, MD 00 0000 000000000 - 0000
000000 00000000000 Corporation PA 000 000.00 00000000 000.00
000000000 00000000 Formerly VC-backed Emeryville, CA 000 00000 000000 - 000 00000
To view EpiThany’s complete competitors history, request access »

EpiThany Executive Team (3)

Name Title Board Seat Contact Info
William Watt Ph.D Co-Founder, President, Board Member & Chief Executive Officer
David Poston Chief Operating Officer
Mary Disis MD Scientific Co-Founder
To view EpiThany’s complete executive team members history, request access »

EpiThany Board Members (3)

Name Representing Role Since
Martin Simonetti Sr. Self Board Member 000 0000
Michael Gallatin Ph.D Self Board Member 000 0000
William Watt Ph.D EpiThany Co-Founder, President, Board Member & Chief Executive Officer 000 0000
To view EpiThany’s complete board members history, request access »

EpiThany Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
WRF Capital Venture Capital Minority 000 0000 000000 0
To view EpiThany’s complete investors history, request access »